iMedi.co.uk

Laevolac 3.3g/5ml Oral Solution

Document: label-leaflet ACTAVIS_PL 05061-0001 change

-30 mm


3 mm

3 mm



actavis


BASELABEL


FRONT LABEL


-183 mm --133,5 mm -


HI b


15 mm


138 mm


15 mm t-►


3 mm


Lactulose 3.3g/5ml Oral Solution

Lactulose


500

ml


5 ml contain 3.3 g lactulose. Oral use. Lift flap for further information about your medicine. Read the package leaflet before use.

Lactulose is used to treat the symptoms of constipation and to treat a special liver disease (portal systemic encephalopathy).

Constipation: Adults and adolescents over 14 years: Starting dose: 15-45 ml (corresponding to 10-30 g lactulose)

Maintenance dose: 15-30 ml (corresponding to 10-20 g lactulose)

Children (7-14 years): Starting dose: 15 ml (corresponding to 10 g lactulose)

Maintenance dose: 10-15 ml (corresponding to 7-10 g lactulose)

Children (1-6 years): Starting dose: 5-10 ml (corresponding to 3-7g lactulose)

Babies: Starting dose: up to 5 ml (corresponding to up to 3g lactulose)

Portal systemic encephalopathy (Liver disease that affects the brain)

Adults: Beginning with 30 - 50 ml 3 times daily (corresponding to 60 - 100 g lactulose).

The dosage has to be adopted to get 2-3 soft stools daily, pH of the stools should be between 5.0 to 5.5.    . a b

Children: The safety and efficacy in children aged 0 - 18 years has not been established.    v actavis

In elderly patients and patients with renal or hepatic insufficiency no special dosage    Marketing Authorisation Holder:

recommendations exist. Keep out of the sight and reach of children.    _ Fresenius Kabi Austria GmbH

Contains traces of sugars (e.g. lactose, galactose, epilactose, tagatose, fructose).    HafnerstraRe 36

Do not store above 25°C.    AAAI3361 PL 05061/0001    8055 Graz, Austria


<^c


^actavis


Lactulose 3.3g/5ml Oral Solution

Lactulose


500

ml


3 mm


LC 662


5 ml contain 3.3 g lactulose. Oral use. Lift flap for further information about your medicine. Read the package leaflet before us Lactulose is used to treat the symptoms of constipation and to treat a special liver disease (portal systemic encephalopathy).

Constipation: Adults and adolescents over 14 years: Starting dose: 15-45 ml (corresponding to 10-30 g lactulose)

Maintenance dose: 15-30 ml (corresponding to 10-20 g lactulose)

Children (7-14 years): Starting dose: 15 ml (corresponding to 10 g lactulose)

Maintenance dose: 10-15 ml (corresponding to 7-10 g lactulose)

Children (1-6 years): Starting dose: 5-10 ml (corresponding to 3-7g lactulose)

Babies: Starting dose: up to 5 ml (corresponding to up to 3g lactulose)

Portal systemic encephalopathy (Liver disease that affects the brain)

Adults: Beginning with 30 - 50 ml 3 times daily (corresponding to 60 - 100 g lactulose). The dosage has to be adopted to get 2-3 soft stools daily, pH of the stools should be between 5.0 to 5.5. Children: The safety and efficacy in children aged 0 - 18 years has not been established. In elderly patients and patients with renal or

hepatic insufficiency no special dosage recommendations exist.    Exp:    Marketing Authorisation Holder:

Keep out ofthe sight and reach of children.    Lot:    Fresenius Kabi Austria GmbH

Contains traces of sugars (e.g. lactose, galactose, epilactose, tagatose, fructose).    HafnerstraRe 36

Do not store above 25°C.    V0055137/05 AAAI3361 PL 05061/0001    8055 Graz, Austria


actavis

Braille reads:-lactulose 3.3g/5ml oral

solution


• o

• O

• •

ob

• o

• o

• o

OB

• o

• o

oo

OO

• •

oo

• o

o#

BO

o#

• o

oo

OO

• o

• •

• o

• o

B o

oo

1

a

c

t

u

1

o

s

e

o#

• •

OO

• •

• •

o#

OB

OB

• O

• •

• O

o#

OO

oo

oo

• •

o*

OO

OB

o#

OO

• o

• •

oo

• o

oo

oo

o#

• O

B B

oo

• o

• o

Nums

i

Point

i

g

/

Nums

5

m

]

• O

• o

• o

• o

ob

• •

oo

• o

• o

• o

oo

• o

o

r

a

1

• O

o#

• o

oo

• •

• o

o#

o#

• O

• o

• o

• •

• o

oo

• o

• o

s

0

1

t

0


1


2


11


12


3 mm

PACKAGE LEAFLET: INFORMATION FOR THE USER    AAAI3361

Lactulose 3.3 g/5 ml Oral Solution

Lactulose

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.

•    Keep this leaflet. You may need to read it again.

•    Ask your pharmacist if you need more information or advice.

•    If you get any side effects, talk to your doctor or pharmacist. This includes any

3 mm


3 mm

possible side effects not listed in this leaflet. See section 4.

• You must talk to a doctor if you do not feel better or if you feel worse after 3 days.

What is in this leaflet:

1.    What Lactulose oral solution is and what it is used for

2.    What you need to know before you take Lactulose oral solution

3.    How to take Lactulose oral solution

4.    Possible side effects

5.    How to store Lactulose oral solution

6.    Contents of the pack and other information


3 mm

For constipation:

Starting dose

Maintenance dose

Adults

15-45 ml

corresponding to 10-30 g lactulose

15-30 ml

corresponding to 10-20 g lactulose

Use in children and adolescents

Starting dose

Maintenance dose

Adolescents over 14 years

15-45 ml

corresponding to 10-30 g lactulose

15-30 ml

corresponding to 10-20 g lactulose

Children (7-14 years)

15 ml

corresponding to 10 g lactulose

10-15 ml

corresponding to 7-10 g lactulose

3 mm


Children (1-6 years)


5-10 ml


Babies


up to 5 ml


3 mm


corresponding to 3-7 g lactulose


corresponding to up to 3 g lactulose


Thereafter the dose can be reduced individually.

The daily dose should be taken once during breakfast. It can be taken for 2-3 days until the desired effect is achieved since Lactulose oral solution is not degraded until t reaches the colon.

For portal systemic encephalopathy (Liver disease that affects the brain)

Adults:

Beginning with 30 - 50 ml 3 times daily (corresponding to 60 - 100 g lactulose). The


3 mm

3    4

3 mm

3 mm

£

E

1. WHAT LACTULOSE ORAL SOLUTION IS AND WHAT IT IS USED FOR

Lactulose oral solution contains the active substance lactulose. Lactulose is a laxative and it makes the stool softer and easier to pass, by drawing water into the bowel. It is not absorbed into your body and reaches the colon unchanged.

Lactulose oral solution is used to:

E

E

E

E

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LACTULOSE ORAL SOLUTION Do not take Lactulose oral solution:

•    if you are allergic to lactulose or any of the other ingredients of this medicine (listed in section 6).

•    if you suffer from

•    galactosaemia (a severe genetic disorder where you cannot digest galactose),

E

E

•    treat the symptoms of constipation

•    treat a special liver disease (portal systemic encephalopathy)

You must talk to a doctor if you do not feel better or if you feel worse after 3 days.

3 mm

• acute inflammatory bowel disease (like Crohn's disease or ulcerative colitis), blockage in your bowel (apart from normal constipation), digestive perforation or risk of digestive perforation, abdominal pain of undetermined cause.

3 mm


3 mm

13    14

3 mm

3 mm

dosage has to be adopted to get 2-3 soft stools daily, pH of the stools should be

If you forget to take Lactulose oral solution

between 5.0 to 5.5.

If you forget to take a dose of Lactulose oral solution, do not worry. Just take the

Use in elderly patients and patients with renal or hepatic insufficiency:

next dose at the usual time. Do not take a double dose to make up for a forgotten

No special dosage recommendations exist.

dose.

Use in children and adolescents:

E

E

If you stop taking Lactulose oral solution

E

E

The safety and efficacy in children aged 0 - 18 years has not been established.

E

E

The desired effect of the medicine may not be achieved.

E

E

If you take more Lactulose oral solution than you should

If you have any further questions on the use of this medicine, ask your doctor or

In case of overdosage, you may experience diarrhoea and abdominal pain. Contact your doctor or pharmacist if you have taken more Lactulose oral solution than you should.

3 mm

pharmacist.

3 mm


5    6

3 mm

3 mm

E

E

Warnings and precautions

Talk to your doctor or pharmacist before taking Lactulose.

Please tell your doctor before taking Lactulose oral solution if you suffer from gastro-cardiac syndrome (Roemheld syndrome). If you have symptoms like meteorism or bloating after using it, stop the treatment and consult your doctor. In these cases your doctor will supervise the treatment carefully.

Longterm use of unadjusted dosages (exceeding 2-3 soft stools per day) or misuse can lead to diarrhoea and disturbance of the electrolytes balance.

If you are an elderly patient or a patient in bad general condition and take Lactulose oral solution for more than a 6 month period, your doctor will regularly check your blood electrolytes.

E

E

E

E

Patients with portal systemic encephalopathy should avoid concomitant administration of other laxatives, because it hinders the individualization of drug dose.

Please do not use Lactulose oral solution without medical advice for more than two weeks.

From the route of synthesis Lactulose oral solution may contain traces of sugars.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

During the treatment with laxatives you should drink sufficient amounts of fluids (approx. 2 l/day, equal to 6-8 glasses).

E

E

3 mm

3 mm

7

8

3 mm

3 mm

E

E

Children

Lactulose oral solution should not normally be given to infants and smaller children as it can disturb the normal reflexes for passing stools. In special circumstances your doctor may prescribe Lactulose oral solution for a child, infant or baby. In these cases your doctor will supervise the treatment carefully.

Other medicines and Lactulose Oral Solution

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Lactulose oral solution may increase the loss of potassium induced by other drugs (e.g. thiazides, steroids and amphothericin B). Concomitant use of cardiac glycosides can increase the effect of the glycosides through potassium deficiency.

With increasing dosage a decrease of pH-value in the colon is found. Therefore drugs

E

E

E

E

which are released in the colon pH-dependently (e.g. 5-ASA) can be inactivated. Lactulose oral solution with food and drink

Lactulose oral solution can be taken with or without food. There are no restrictions on what you can eat or drink.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Lactulose oral solution will not affect your ability to drive safely or use machines.

E

E

3 mm

3 mm


15    16

3 mm

3 mm

E

E

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported with Lactulose oral solution:

Very common:

•    Flatulence (wind), especially during the first few days of treatment. This usually disappears after a couple of days

•    When a higher dose than recommended is used, you may experience abdominal pain and diarrhoea.

E

E

E

E

Common:

•    Nausea (feeling sick)

•    Vomiting

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme.

Website: www.mhra.gov.uk/yellowcard.

E

E

3 mm

3 mm

17

18

3 mm

3 mm

5. HOW TO STORE LACTULOSE ORAL SOLUTION

6. CONTENTS OF THE PACK AND OTHER INFORMATION

E

E

Do not store above 25°C. Keep container tightly closed.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label of the bottle (EXP: mm yyyy). The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

E

E

E

E

What Lactulose oral solution contains

•    The active substance is Lactulose (as lactulose liquid).

5 ml of Lactulose oral solution contains 3.3 g lactulose.

•    There are no other ingredients.

What Lactulose oral solution looks like and contents of the pack

Lactulose oral solution is a clear, viscous liquid, colourless or pale brownish-yellow solution and is available in glass, PET bottles or HDPE bottles containing 200 ml, 300 ml, 500 ml and 1000 ml.

E

E

A measuring cup (polypropylene) with filling marks is added as measuring device.

3 mm

3 mm


19    20


9    10

3 mm

3 mm

Lactulose oral solution contains milk sugar (lactose), galactose, epilactose,

Take your doses at the same time each day. The dose may be given once daily, for

tagatose or fructose.

example during breakfast, or divided up to three doses a day.

Please refer to section "Warnings and precautions".

Swallow the medicine quickly. Do not keep it in your mouth.

15 ml of Lactulose oral solution contain 42.7 KJ (10.2 kcals) = 0.21 bu. The dose used

You can take Lactulose oral solution undiluted or diluted in some liquid. Use the

for treatment may need to be taken into considerations for diabetics.

E

E

measuring cup provided.

E

E

3. HOW TO TAKE LACTULOSE ORAL SOLUTION

E

E

During the treatment with laxatives you should drink sufficient amounts of fluids (approx. 2 l/day, equal to 6-8 glasses).

E

E

Always take Lactulose oral solution exactly as described in this leaflet or as your

doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The recommended dose is:

3 mm

3 mm


3 mm

3 mm

Not all pack sizes may be marketed.

Manufacturer

E

E

Marketing Authorisation Holder

Fresenius Kabi Austria GmbH HafnerstraRe 36 8055 Graz, Austria Tel.: +43 316 249 0

E

E

E

E

Fresenius Kabi Austria GmbH EstermannstraRe 17 4020 Linz, Austria Tel.: +43 732 7651 0 Fax: +43 732 7651 2429 office@fresenius-kabi.com

E

E

Fax: +43 316 249 1470 Info-atgr@fresenius-kabi.com

For any information about this medicine, please contact the local representative of

the Marketing Authorisation Holder.

This leaflet was last revised in September 2015.

AAAI3361

3 mm

3 mm


emma.cornf

orth@mhra.

gov.uk


Digitally signed by

emma.cornforth@mhra.gov.u

k

DN:

cn=emma.cornforth@mhra.g

ov.uk

Date: 2015.11.25 13:00:03 Z


BASELABEL


FRONT LABEL


183 mm

30 mm --133,5 mm-| |-<15 mm


138 mm


15 mm t-►


3 mm


3 mm

3 mm



actavis


Lactulose 3.3g/5ml Oral Solution

Lactulose


300

ml


^actavis


Lactulose 3.3g/5ml Oral Solution

Lactulose


300

ml


5 ml contain 3.3 g lactulose. Oral use. Lift flap for further information about your medicine. Read the package leaflet before use. Lactulose is used to treat the symptoms of constipation and to treat a special liver disease (portal systemic encephalopathy). Constipation: Adults and adolescents over 14 years: Starting dose: 15-45 ml (corresponding to 10-30 g lactulose)

Maintenance dose: 15-30 ml (corresponding to 10-20 g lactulose)

Children (7-14 years): Starting dose: 15 ml (corresponding to 10 g lactulose)

Maintenance dose: 10-15 ml (corresponding to 7-10 g lactulose)


Children (1-6 years): Starting dose: 5-10 ml (corresponding to 3-7g lactulose)

Babies: Starting dose: up to 5 ml (corresponding to up to 3g lactulose)

Portal systemic encephalopathy (Liver disease that affects the brain)

Adults: Beginning with 30 - 50 ml 3 times daily (corresponding to 60 - 100 g lactulose).

The dosage has to be adopted to get 2-3 soft stools daily, pH of the stools should be between 5.0 to 5.5. Children: The safety and efficacy in children aged 0 - 18 years has not been established.

In elderly patients and patients with renal or hepatic insufficiency no special dosage recommendations exist. Keep out of the sight and reach of children.

Contains traces of sugars (e.g. lactose, galactose, epilactose, tagatose, fructose).    | p |


Do not store above 25°C.


AAAI3358 PL 05061/0001


<^c


actavis

Marketing Authorisation Holder: Fresenius Kabi Austria GmbH HafnerstraRe 36 8055 Graz, Austria


3 mm


LC 661


5 ml contain 3.3 g lactulose. Oral use. Lift flap for further information about your medicine. Read the package leaflet before use.

Lactulose is used to treat the symptoms of constipation and to treat a special liver disease (portal systemic encephalopathy).

Constipation: Adults and adolescents over 14 years: Starting ^Maintenance dose: 15-30 ml (corresponding to 10-20 g lactulose)

Children (7-14 years): Starting dose: 15 ml (corresponding to 10 g lactulose)

Maintenance dose: 10-15 ml (corresponding to 7-10 g lactulose)

Children (1-6 years): Starting dose: 5-10 ml (corresponding to 3-7g lactulose)

Babies: Starting dose: up to 5 ml (corresponding to up to 3g lactulose)

Portal systemic encephalopathy (Liver disease that affects the brain)

Adults: Beginning with 30 - 50 ml 3 times daily (corresponding to 60 - 100 g lactulose). The dosage has to be adopted to get 2-3 soft stools daily, pH of the stools should be between 5.0 to 5.5. Children: The safety and efficacy in children aged 0 - 18 years has not been established. In elderly patients and patients with renal or

hepatic insufficiency no special dosage recommendations exist.    Exp:    Marketing Authorisation Holder:

Keep out ofthe sight and reach of children.    Lot:    Fresenius Kabi Austria GmbH

Contains traces of sugars (e.g. lactose, galactose, epilactose, tagatose, fructose).    HafnerstraRe 36

Do not store above 25°C.    V0055129/05 AAAI3358 PL 05061/0001    8055 Graz, Austria


actavis

Braille reads:-lactulose 3.3g/5ml oral

solution


o

OO

OO

• •

OO

o

o#

o

o#

o

OO

OO

o

• •

• o

• o

• o

OO

1

a

c

t

1

0

s

e

09

OO

• •

• •

o#

09

09

• O

• •

• O

09

OO

OO

OO

• •

o*

OO

09

o#

OO

o

9 9

OO

o

OO

OO

o#

90

9 9

OO

o

o

Nums

i

Point

i

g

/

Nums

5

m

]

• O

90

o

90

09

9 9

OO

90

90

90

OO

90

o

r

a

1

o

O#

o

OO

• •

o

o#

o#

o

• O

o

• •

o

OO

• o

• o

s

0

1

t

0


1


2


11


12


3 mm

3 mm

E

E

PACKAGE LEAFLET: INFORMATION FOR THE USER AAAI3358

Lactulose 3.3 g/5 ml Oral Solution

Lactulose

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you.

Keep this leaflet. You may need to read it again.

Ask your pharmacist if you need more information or advice.

If you get any side effects, talk to your doctor or pharmacist. This includes any

E

E

E

E

possible side effects not listed in this leaflet. See section 4.

• You must talk to a doctor if you do not feel better or if you feel worse after 3 days.

What is in this leaflet:

1.    What Lactulose oral solution is and what it is used for

2.    What you need to know before you take Lactulose oral solution

3.    How to take Lactulose oral solution

4.    Possible side effects

5.    How to store Lactulose oral solution

6.    Contents of the pack and other information

E

E

3 mm

3 mm


3 mm

For constipation:

Starting dose

Maintenance dose

Adults

15-45 ml corresponding to 10-30 g lactulose

15-30 ml corresponding to 10-20 g lactulose

Use in children and adolescents

Starting dose

Maintenance dose

Adolescents over 14 years

15-45 ml corresponding to 10-30 g lactulose

15-30 ml corresponding to 10-20 g lactulose


3 mm

Children (7-14 years)

15 ml

corresponding to 10 g lactulose

10-15 ml corresponding to 7-10 g lactulose

Children (1-6 years)

5-10 ml

corresponding to 3-7 g lactulose

Babies

up to 5 ml

corresponding to up to 3 g lactulose

Thereafter the dose can be reduced individually.

The daily dose should be taken once during breakfast. It can be taken for 2-3 days until the desired effect is achieved since Lactulose oral solution is not degraded until t reaches the colon.

3 mm


3    4


13    14


3 mm

3 mm

E

E

1. WHAT LACTULOSE ORAL SOLUTION IS AND WHAT IT IS USED FOR

Lactulose oral solution contains the active substance lactulose. Lactulose is a laxative and it makes the stool softer and easier to pass, by drawing water into the bowel. It is not absorbed into your body and reaches the colon unchanged.

Lactulose oral solution is used to:

E

E

E

E

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LACTULOSE ORAL SOLUTION Do not take Lactulose oral solution:

•    if you are allergic to lactulose or any of the other ingredients of this medicine (listed in section 6).

•    if you suffer from

•    galactosaemia (a severe genetic disorder where you cannot digest galactose),

E

E

•    treat the symptoms of constipation

•    treat a special liver disease (portal systemic encephalopathy)

You must talk to a doctor if you do not feel better or if you feel worse after 3 days.

3 mm

• acute inflammatory bowel disease (like Crohn's disease or ulcerative colitis), blockage in your bowel (apart from normal constipation), digestive perforation or risk of digestive perforation, abdominal pain of undetermined cause.

3 mm


3 mm

3 mm

3 mm

For portal systemic encephalopathy (Liver disease that affects the brain)

If you take more Lactulose oral solution than you should

Adults:

In case of overdosage, you may experience diarrhoea and abdominal pain. Contact

Beginning with 30 - 50 ml 3 times daily (corresponding to 60 - 100 g lactulose). The

your doctor or pharmacist if you have taken more Lactulose oral solution than you

dosage has to be adopted to get 2-3 soft stools daily, pH of the stools should be

should.

between 5.0 to 5.5.

E

E

If you forget to take Lactulose oral solution

E

E

Use in elderly patients and patients with renal or hepatic insufficiency:

E

E

If you forget to take a dose of Lactulose oral solution, do not worry. Just take the

E

E

No special dosage recommendations exist.

next dose at the usual time. Do not take a double dose to make up for a forgotten dose.

Use in children and adolescents:

The safety and efficacy in children aged 0 - 18 years has not been established.

3 mm

If you stop taking Lactulose oral solution

The desired effect of the medicine may not be achieved.

3 mm


5

6

3 mm

3 mm

E

E

Warnings and precautions

Talk to your doctor or pharmacist before taking Lactulose.

Please tell your doctor before taking Lactulose oral solution if you suffer from gastro-cardiac syndrome (Roemheld syndrome). If you have symptoms like meteorism or bloating after using it, stop the treatment and consult your doctor. In these cases your doctor will supervise the treatment carefully.

Longterm use of unadjusted dosages (exceeding 2-3 soft stools per day) or misuse can lead to diarrhoea and disturbance of the electrolytes balance.

If you are an elderly patient or a patient in bad general condition and take Lactulose oral solution for more than a 6 month period, your doctor will regularly check your blood electrolytes.

Patients with portal systemic encephalopathy should avoid concomitant

E

E

E

E

administration of other laxatives, because it hinders the individualization of drug dose.

Please do not use Lactulose oral solution without medical advice for more than two weeks.

From the route of synthesis Lactulose oral solution may contain traces of sugars.

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

During the treatment with laxatives you should drink sufficient amounts of fluids (approx. 2 l/day, equal to 6-8 glasses).

E

E

3 mm

3 mm

7

8

3 mm

3 mm

E

E

Children

Lactulose oral solution should not normally be given to infants and smaller children as it can disturb the normal reflexes for passing stools. In special circumstances your doctor may prescribe Lactulose oral solution for a child, infant or baby. In these cases your doctor will supervise the treatment carefully.

Other medicines and Lactulose Oral Solution

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Lactulose oral solution may increase the loss of potassium induced by other drugs (e.g. thiazides, steroids and amphothericin B). Concomitant use of cardiac glycosides can increase the effect of the glycosides through potassium deficiency.

With increasing dosage a decrease of pH-value in the colon is found. Therefore drugs

E

E

E

E

which are released in the colon pH-dependently (e.g. 5-ASA) can be inactivated. Lactulose oral solution with food and drink

Lactulose oral solution can be taken with or without food. There are no restrictions on what you can eat or drink.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Lactulose oral solution will not affect your ability to drive safely or use machines.

E

E

3 mm

3 mm

9

10

3 mm

3 mm

Lactulose oral solution contains milk sugar (lactose), galactose, epilactose, tagatose or fructose.

Please refer to section "Warnings and precautions".

Take your doses at the same time each day. The dose may be given once daily, for example during breakfast, or divided up to three doses a day.

Swallow the medicine quickly. Do not keep it in your mouth.

15 ml of Lactulose oral solution contain 42.7 KJ (10.2 kcals) = 0.21 bu. The dose used for treatment may need to be taken into considerations for diabetics.

E

E

You can take Lactulose oral solution undiluted or diluted in some liquid. Use the measuring cup provided.

E

E

3. HOW TO TAKE LACTULOSE ORAL SOLUTION

Always take Lactulose oral solution exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

3 mm

E

E

During the treatment with laxatives you should drink sufficient amounts of fluids (approx. 2 l/day, equal to 6-8 glasses).

The recommended dose is:

3 mm

E

E


15

16

3 mm

3 mm

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

• When a higher dose than recommended is used, you may experience abdominal pain and diarrhoea.

E

E

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported with Lactulose oral solution:

Very common:

• Flatulence (wind), especially during the first few days of treatment. This usually disappears after a couple of days

E

E

E

E

Common:

•    Nausea (feeling sick)

•    Vomiting

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly

E

E

3 mm

3 mm

17

18

3 mm

3 mm

E

E

via the Yellow Card Scheme.

Website: www.mhra.gov.uk/yellowcard.

5. HOW TO STORE LACTULOSE ORAL SOLUTION

Do not store above 25°C. Keep container tightly closed.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label of the bottle (EXP: mm yyyy). The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will

E

E

E

E

help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Lactulose oral solution contains

•    The active substance is Lactulose (as lactulose liquid).

5 ml of Lactulose oral solution contains 3.3 g lactulose.

•    There are no other ingredients.

What Lactulose oral solution looks like and contents of the pack

Lactulose oral solution is a clear, viscous liquid, colourless or pale brownish-yellow solution and is available in glass, PET bottles or HDPE bottles containing 200 ml, 300 ml, 500 ml and 1000 ml.

E

E

3 mm

3 mm

19

20

3 mm

3 mm

E

E

A measuring cup (polypropylene) with filling marks is added as measuring device. Not all pack sizes may be marketed.

Marketing Authorisation Holder

Fresenius Kabi Austria GmbH HafnerstraRe 36 8055 Graz, Austria

E

E

E

E

Manufacturer

Fresenius Kabi Austria GmbH EstermannstraRe 17 4020 Linz, Austria Tel.: +43 732 7651 0 Fax: +43 732 7651 2429 office@fresenius-kabi.com

E

E

Tel.: +43 316 249 0

Fax: +43 316 249 1470

Info-atgr@fresenius-kabi.com

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.

This leaflet was last revised in September 2015.

AAAI3358

3 mm

3 mm